stockrowNatera, Inc.
NTRA Healthcare Diagnostics & Research
Natera, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 35.9% from fiscal 2024.
- Revenue
- +34.1%
- EPS
- +34.4%
- Free cash flow
- −85.8%
- Total debt
- −0.06%
Quarter to September 2026, against a year earlier
Follow NTRA
Alert me
Natera, Inc. (NTRA) Total debt
Natera, Inc.'s total debt at the end of fiscal 2025 was $80.3M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $80.3M. Over the past ten years it has ranged from $42.1M (fiscal 2015) to $363.3M (fiscal 2023); the current reading is higher than 27% of that period. Natera, Inc. ranks 26th of 46 Diagnostics & Research companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $80.3M | (0.05%) |
| FY2024 | $80.4M | (77.88%) |
| FY2023 | $363.3M | 0.37% |
| FY2022 | $362.0M | 9.55% |
| FY2021 | $330.4M | 30.85% |
| FY2020 | $252.5M | 104.03% |
| FY2019 | $123.8M | 0.22% |
| FY2018 | $123.5M | 0.27% |
| FY2017 | $123.2M | 148.22% |
| FY2016 | $49.6M | 17.90% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $80.3M | 0.00% |
| Jun 2026 | $80.3M | (0.02%) |
| Mar 2026 | $80.3M | (0.02%) |
| Dec 2025 | $80.3M | (0.02%) |
| 42 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| IQV IQVIA Holdings Inc. compare | $16.1B |
| DGX Quest Diagnostics Incorporated compare | $5.6B |
| LH Labcorp Holdings Inc. compare | $5.3B |
| WAT Waters Corporation compare | $4.9B |
| A Agilent Technologies, Inc. compare | $3.6B |
| MTD Mettler-Toledo International, Inc. compare | $2.1B |
| ILMN Illumina, Inc. compare | $1.8B |
| IDXX IDEXX Laboratories, Inc. compare | $374.9M |
| NTRA Natera, Inc. | $80.3M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on NTRA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement